Neurogene Inc.
NGNE
$17.17
$0.372.20%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -38.69% | -55.92% | -37.98% | 119.44% | -16.17% |
| Total Depreciation and Amortization | -2.54% | -0.73% | 0.86% | -8.61% | 67.27% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 131.59% | 385.58% | 163.80% | -3,468.71% | -27.96% |
| Change in Net Operating Assets | 57.53% | -175.65% | -163.32% | -709.61% | 264.80% |
| Cash from Operations | -34.54% | -70.40% | -59.72% | -66.72% | -6.74% |
| Capital Expenditure | -103.66% | -460.98% | -124.14% | 42.34% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -35,224.39% | -28,697.56% | 103,324.14% | 11,735.14% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -20.00% | -166.67% | -120.00% | -700.00% | -- |
| Issuance of Common Stock | 308.57% | 1,975.00% | 461.61% | -97.92% | 105.88% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 100.00% | -- | -- | -- |
| Cash from Financing | 107.14% | 563.95% | -6,197.20% | 304,083.87% | -10,900.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -229.22% | -311.88% | 113.07% | 1,094.65% | -24.63% |
